Lazard Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSI
Lazard Asset Management's BDSI Position: Q1 2022 in Review
Lazard Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 25,345 shares — an estimated $78K sold.
Lazard Asset Management first reported a position in BDSI in Q3 2014 and held it in 9 quarters. The position peaked at $104K in Q3 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Lazard Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Lazard Asset Management sold 25,345 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $78K.
- Lazard Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2014 and held it in 9 quarters.
- Lazard Asset Management's BioDelivery Sciences International, Inc. position peaked at $104K in Q3 2014.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.